You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-PLA2G16 (PLA2G16) Antibodies

Full name:
anti-HRAS-Like Suppressor 3 Antibodies (PLA2G16)
On are 55 HRAS-Like Suppressor 3 (PLA2G16) Antibodies from 12 different suppliers available. Additionally we are shipping PLA2G16 Proteins (18) and many more products for this protein. A total of 80 PLA2G16 products are currently listed.
AdPLA, C78643, H-REV107-1, Hrasls3, Hrev107, HREV107-1, HREV107-3, HRSL3, MLP-3
list all antibodies Gene Name GeneID UniProt
PLA2G16 11145 P53816
PLA2G16 225845 Q8R3U1
PLA2G16 24913 P53817

Show all species

Show all synonyms

Most Popular Reactivities for anti-PLA2G16 (PLA2G16) Antibodies

Select your species and application

anti-Human PLA2G16 Antibodies:

anti-Mouse (Murine) PLA2G16 Antibodies:

anti-Rat (Rattus) PLA2G16 Antibodies:

All available anti-PLA2G16 Antibodies

Go to our pre-filtered search.

More Antibodies against PLA2G16 Interaction Partners

Human HRAS-Like Suppressor 3 (PLA2G16) interaction partners

  1. study uncovers two competing processes triggered by Picornaviridae virus entry: activation of a pore-activated clearance pathway and recruitment of a PLA2G16 phospholipase to enable genome release

  2. Demonstrate increased PLA2G16 expression activates the MAPK (show MAPK1 Antibodies) pathway to enhance osteosarcoma metastasis.

  3. our results revealed that H-rev107 (show HRASLS Antibodies) is also involved in lipid accumulation in liver cells through the POR (show POR Antibodies) pathway via its PLA2 (show YWHAZ Antibodies) activity.

  4. Results show that osteosarcoma patients with metastasis showed higher expression of PLA2G16 at both the mRNA and protein levels and shorter overall survival suggesting it as significant prognostic factor for poor outcome.

  5. the flexible main loop of H-REV107, but not that of TIG3, is critical for its NTD to modulate its CTD in inducing cell death.

  6. crystal structure of the HRASLS3-LRAT (show LRAT Antibodies) chimeric enzyme in a thioester catalytic intermediate state revealed a major structural rearrangement accompanied by three-dimensional domain swapping dimerization not observed in native HRASLS (show HRASLS Antibodies)

  7. several mutant p53 (show TP53 Antibodies) proteins bind the Pla2g16 promoter at E26 transformation-specific (ETS (show ETS1 Antibodies)) binding motifs and knockdown of ETS2 (show ETS2 Antibodies) suppressed mutant p53 (show TP53 Antibodies) induction of Pla2g16.

  8. Our study further suggests that the PLA/AT activity of H-rev107 may play an important role in H-rev107-mediated RAS suppression.

  9. an alternate mechanism for AdPLA in promoting adipose tissue lipolysis that is not contingent on the release of arachidonic acid and that is compatible with its combined PLA(1 (show POU2F3 Antibodies))/A(2) activity

  10. Data show that acyl-modified forms of HRAS (show HRAS Antibodies)-like tumor suppressors HRASLS2 (show HRASLS2 Antibodies) and HRASLS3 mimicking lipolytic activity of lecithin retinol acyltransferase LRAT (show LRAT Antibodies).

Mouse (Murine) HRAS-Like Suppressor 3 (PLA2G16) interaction partners

  1. several mutant p53 (show TP53 Antibodies) proteins bind the Pla2g16 promoter at E26 transformation-specific (ETS (show ETS1 Antibodies)) binding motifs and knockdown of ETS2 (show ETS2 Antibodies) suppressed mutant p53 (show TP53 Antibodies) induction of Pla2g16.

  2. H-rev107 (show HRASLS Antibodies), through PTGDS (show PTGDS Antibodies), suppressed cell migration and invasion. Data suggest that the PGD2 (show PTGDS Antibodies)-cAMP-SOX9 (show SOX9 Antibodies) signal pathway might play an important role in H-rev107 (show HRASLS Antibodies)-mediated cancer cell invasion in testes.

  3. H-rev107 (show HRASLS Antibodies) interferes with the biosynthesis of ether-type lipids and is responsible for the dysfunction of peroxisomes in H-rev107 (show HRASLS Antibodies)-expressing cells.

  4. identification of an Sp1 (show SP1 Antibodies)/Sp3 (show SP3 Antibodies)-binding GC-box required for the transcription of H-rev107 (H-rev107 (show HRASLS Antibodies))

  5. study found that AdPLA that was previously known as H-Rev-107 (show HRASLS Antibodies)/HRASLS3 is an adipose-specific, calcium-dependent histidine PLA2 (show PLA2G2A Antibodies)

  6. HRASLS3 as one of the downstream effectors of PPARgamma (show PPARG Antibodies) action in adipogenesis.

Cow (Bovine) HRAS-Like Suppressor 3 (PLA2G16) interaction partners

  1. Single nucleotide polymorphisms in the adipose specific phospholipase A2 are associated with growth traits in cattle.

PLA2G16 Antigen Profile

Antigen Summary

gene whose expression is suppressed by HRAS

Alternative names and synonyms associated with PLA2G16

  • phospholipase A2, group XVI (PLA2G16) antibody
  • HRAS-like suppressor 3 (LOC100343759) antibody
  • phospholipase A2, group XVI (Pla2g16) antibody
  • AdPLA antibody
  • C78643 antibody
  • H-REV107-1 antibody
  • Hrasls3 antibody
  • Hrev107 antibody
  • HREV107-1 antibody
  • HREV107-3 antibody
  • HRSL3 antibody
  • MLP-3 antibody

Protein level used designations for PLA2G16

HRAS-like suppressor 3 , H-rev 107 protein homolog , group XVI phospholipase A1/A2 , group XVI phospholipase A2 , Ca-independent phospholipase A1/2 , HRAS-like suppressor 1 , adipose-specific PLA2 , adipose-specific phospholipase A2 , renal carcinoma antigen NY-REN-65 , H-rev 107 protein , HRAS like suppressor 3 , LRAT-like protein 3 , Hras-revertant gene 107 (expression down-regulated in HRAS-transformed rat 208F fibroblasts)

451279 Pan troglodytes
476045 Canis lupus familiaris
100190820 Pongo abelii
100343759 Oryctolagus cuniculus
11145 Homo sapiens
225845 Mus musculus
506802 Bos taurus
24913 Rattus norvegicus
Selected quality suppliers for anti-PLA2G16 (PLA2G16) Antibodies
Did you look for something else?